Skip to main navigation Skip to search Skip to main content

4D-Printed Sandwich-Structured Metamaterial Intestinal Stents for Palliative Tumor Therapy

  • Harbin Institute of Technology
  • Nanjing University
  • The First Affiliated Hospital of Harbin Medical University
  • Peking University

Research output: Contribution to journalArticlepeer-review

Abstract

Intestinal obstruction is a common complication caused by colorectal cancer, and the implantation of stents has become an indispensable palliative treatment strategy for non-surgical eligible patients. However, the lack of sustained anti-tumor efficacy and wear caused by configuration or deformation discrepancies has led to the recurrence of stenosis, posing a significant challenge in clinical treatment. Here, we reported an intestine-specific, application-driven 4D-printed sandwich-structured metamaterial intestinal stent platform, achieving the triple goals of sustained anti-tumor effects, customized configuration and performance, and rapid relief of intestinal obstruction. Specifically, the platform comprised an outer Janus layer designed for synergistic photothermal-and-drug anti-tumor effects, an intermediate layer of biomimetic gradient metamaterials for structural support and coordinated deformation, and a hydrophobic inner layer to mitigate the risk of restenosis. Overall, this study presented a multifunctional intestinal stent built upon a scalable design paradigm, offering an innovative and clinically translatable therapeutic strategy for personalized colorectal cancer management.

Original languageEnglish
JournalAdvanced Materials
DOIs
StateAccepted/In press - 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 4D printing
  • anti-tumor
  • intestinal obstruction
  • intestinal stent
  • metamaterial

Fingerprint

Dive into the research topics of '4D-Printed Sandwich-Structured Metamaterial Intestinal Stents for Palliative Tumor Therapy'. Together they form a unique fingerprint.

Cite this